Changes in decadal precipitation and JULES inundation between 1990–1999 and 2089–2098. حسب Nic Gedney (19762301)

Contemporary mean inundation fraction in the Amazon basin. حسب Nic Gedney (19762301)

Characteristics of patients based on case classification N = 100 (baseline validation cohort). حسب Ann-Marcia C. Tukpah (15270829)

Level of Th1/Th2/Th17 cytokines in the serum samples of acute phase of infection in fatal cases (AFC) (n = 10), acute phase of infection in survived cases (ASC) (n = 13), recovered... حسب Rima R. Sahay (10122217)

Risk factors for mucormycosis among never-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. حسب Manickam Ponnaiah (294619)

الموضوعات:

Risk factors for mucormycosis among ever-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. حسب Manickam Ponnaiah (294619)

الموضوعات:

Directed acyclic graph of Post COVID-19 rhino orbito cerebral mucormycosis for (a) ever-hospitalised and (b) never-hospitalised patients. حسب Manickam Ponnaiah (294619)

الموضوعات:

The decrease in embryonic survival after stress coincides with a decrease in oocyte and embryo size. حسب Sarah Fausett (11812818)

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. حسب Kaley M. Wilburn (12060476)

Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case–control study حسب Mohd Azri Mohd Suan (7572407)

"…A total of 255 case–control patient pairs were enrolled. The multivariable analysis indicated that having a history of blood or blood product transfusion before 1992 (adjusted odds ratio [AOR] = 6.99, 95% confidence interval [CI]: 3.73–13.81), injection drug use (AOR = 6.60, 95% CI: 3.66–12.43), imprisonment (AOR = 4.58, 95% CI: 1.62–16.40), tattooing (AOR = 3.73, 95% CI: 1.37–12.00), having more than one sexual partner (AOR = 2.06, 95% CI: 1.16–3.69), piercing (AOR = 1.71, 95% CI: 1.04–2.80), and having only secondary education (AOR = 1.92, 95% CI: 1.06–3.57) were independently associated with hepatitis C. …"

Thoracic computed tomography scan of Case 2 and 3 before and after specific antibiotic treatment. حسب Fanfan Xing (9251093)

الموضوعات:

Image_5_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.PNG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Table_2_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.DOCX حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Image_2_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.PNG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Image_10_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.PNG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Image_3_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.PNG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Image_4_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.PNG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Image_7_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.JPEG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Image_1_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.JPEG حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"

Table_1_Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.DOCX حسب Sanja Petrovic Pajic (14022042)

"…At the presentation at ages 17 (Case 1) and 18 years (Case 2), both had reduced visual acuity (Snellen): (Case 1) right eye (RE):CF 3m, left eye (LE):0.6, (Case 2) RE:0.2, LE:0.15; and color vision (Ishihara): (Case 1) 1/15 and 13/15; (Case 2) 2/15 and 3/15. …"